5Cuneo A, Bigoni R, Emmanuel B, et al. Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis. Leukemia, 1998 ; 12 : 1718 - 1723
6Thiele J,Kvasnicka HM,Varus E, et al. Megakaryocyte features and bcr/abl translocation in chronic myeloid leukemia following imatinib mesylate (STI571) therapy-a fluorescence in-situ hybridization study. Leuk-Lymphoma, 2004; 45 : 1627 - 1631
7Raanani P, Ben-Bassat I, Gan S, et al. Assessment of the response to imatinib in chronic myeloid leukemia patients-comparison between the FISH, multiplex and RT-PCR methods. Eur J Haematol, 2004 ; 73 : 243 - 250
8Cox MC, Maffei L, Buffolino S, et al. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias. Am J Clin Pathol, 1998; 109:24 -31
9Dewald GW, Wyatt WA, Juneau AL, et al. Highly sensitive fluorescence in situ hybridization method to detect double bcr/abl fusion and monitor response to therapy in chronic myeloid leukemia. Blood, 1998; 91 : 3357 -3365
